malondialdehyde has been researched along with Coronary Vasospasm in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ashikaga, T; Isobe, M; Nomoto, H; Nozato, T; Ohno, M; Oumi, T; Sakakibara, A; Satoh, Y; Takahashi, Y | 1 |
Fujita, H; Ito, T; Ohte, N; Sugiura, T; Tani, T | 1 |
Anazawa, T; Fuji, T; Furuya, S; Hirayama, A; Iida, K; Kawamata, H; Kumabe, T; Matsumoto, M; Nagao, K; Sato, Y; Takahashi, H; Tani, S | 2 |
Belch, JJ; Bridges, AB; McNeill, GP; Niblock, A; Pringle, TH | 1 |
Glogar, D; Kaliman, J; Sinzinger, H; Sochor, H; Stefenelli, T | 1 |
6 other study(ies) available for malondialdehyde and Coronary Vasospasm
Article | Year |
---|---|
Malondialdehyde-Modified Low Density Lipoprotein as Oxidative-Stress Marker in Vasospastic Angina Patients.
Topics: Biomarkers; Coronary Angiography; Coronary Vasospasm; Diagnosis, Differential; Electrocardiography; Female; Follow-Up Studies; Humans; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Prognosis; Retrospective Studies; Risk Factors; Time Factors | 2017 |
Increased circulating malondialdehyde-modified low-density lipoprotein levels in patients with ergonovine-induced coronary artery spasm.
Topics: Aged; Angina Pectoris; Cardiovascular Agents; Coronary Angiography; Coronary Vasospasm; Coronary Vessels; Endothelium, Vascular; Ergonovine; Female; Humans; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Nitroglycerin; Statistics as Topic | 2015 |
Treatment of coronary spastic angina with a statin in addition to a calcium channel blocker: a pilot study.
Topics: Angina Pectoris, Variant; Calcium Channel Blockers; Cholesterol, HDL; Cholesterol, LDL; Coronary Vasospasm; Dihydropyridines; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipid Metabolism; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Pilot Projects; Pravastatin | 2008 |
Association of plasma level of malondialdehyde-modified low-density lipoprotein with coronary plaque morphology in patients with coronary spastic angina: implication of acute coronary events.
Topics: Acute Coronary Syndrome; Aged; Aorta; Cardiac Catheterization; Coronary Angiography; Coronary Artery Disease; Coronary Sinus; Coronary Vasospasm; Female; Humans; Incidence; Lipoproteins, LDL; Logistic Models; Male; Malondialdehyde; Middle Aged; Risk Factors; Ultrasonography, Interventional | 2009 |
Free radical markers in patients with angina pectoris and normal coronary angiograms.
Topics: Adult; Aged; Angina Pectoris; Coronary Angiography; Coronary Circulation; Coronary Vasospasm; Erythrocytes; Exercise Test; Female; Free Radicals; Glutathione; Humans; Male; Malondialdehyde; Middle Aged; Myocardial Ischemia; Reactive Oxygen Species; Superoxide Dismutase | 1993 |
Humoral regulation during cold-induced coronary arterial spasm.
Topics: Angiotensin II; Blood Platelets; Cold Temperature; Coronary Vasospasm; Epinephrine; Female; Humans; Male; Malondialdehyde; Middle Aged; Norepinephrine; Thromboxane B2 | 1989 |